Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials.

ABSTRACT:

SUBMITTER: Li R 

PROVIDER: S-EPMC12523153 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature